Skip to main content
Tong Ren Tang Technologies Co. Ltd. logo

Tong Ren Tang Technologies Co. Ltd. — Investor Relations & Filings

Ticker · 1666 ISIN · CNE100000585 HKEX Manufacturing
Open in API
Filings indexed 1,685 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1666

About Tong Ren Tang Technologies Co. Ltd.

http://www.tongrentangkj.com

Tong Ren Tang Technologies Co. Ltd. is a leading enterprise specializing in the production and distribution of traditional Chinese medicine (TCM). Originating from the Tong Ren Tang brand established in 1669, the company holds a distinguished heritage, including a history of supplying Chinese medicine to the royal families for 188 years. The core business encompasses the manufacturing and sale of diverse pharmaceutical products, such as Chinese patent medicines, herbal medicines, biological preparations, and antibiotics. Operating across Mainland China and Hong Kong, the company leverages its recognized brand and historical expertise while integrating modern technology to advance the development and global reach of TCM.

Recent filings

Filing Released Lang Actions
Monthly Return for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
ANNOUNCEMENT ON FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2026
Earnings Release Classification · 92% confidence The document is a short formal announcement under Hong Kong Listing Rule 13.09 and the Securities and Futures Ordinance announcing unaudited first quarter financial results (revenue, costs, net profit, assets) for the three months ended 31 March 2026. It provides key highlights only rather than a full interim report. This fits the definition of an initial quarterly earnings announcement (Earnings Release). Q1 2026
2026-04-27 English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 85% confidence The document is a reminder letter to non-registered shareholders about the electronic dissemination arrangement for all future corporate communications (annual report, interim report, meeting notices, circulars, proxy forms, etc.) and includes a reply form for selecting printed copies. It is not a financial report, earnings release, proxy solicitation on a specific meeting, or an audit/annual/interim report itself. It simply announces a change in distribution method of corporate communications. No other precise category applies, so this is a general regulatory announcement—falls under the fallback “Regulatory Filings” (RNS).
2026-04-27 English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 85% confidence The document is a reminder letter to shareholders about the arrangement for electronic dissemination of corporate communications (annual reports, interim reports, notices, circulars, proxy forms, etc.). It does not itself contain any substantive corporate report, financial results, or AGM materials, nor does it announce a dividend, legal proceeding, board change, share issue, or other specific corporate action category. It is a general shareholder communication / regulatory notification about how future communications will be delivered. There is no fitting specialized category, so it defaults to a general Regulatory Filings announcement (RNS).
2026-04-27 English
(Updated) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025
Notice of Dividend Amount Classification · 95% confidence The document is an announcement of the final dividend for the year ended 31 December 2025, including dividend type, amount per share, approval date, ex-dividend date, record date, payment date, and withholding tax details. This fits the definition of a Notice of Dividend Amount.
2026-04-27 English
FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING ON FRIDAY, 12 JUNE 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the 2025 Annual General Meeting, containing instructions for appointing proxies, voting on resolutions, and details of the AGM agenda. This falls under materials sent to shareholders to solicit votes and provide meeting information, which matches the Proxy Solicitation & Information Statement category.
2026-04-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.